The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection
Open accessAbstract
BACKGROUND: Hepatic steatosis is one of the histopathologic features of chronic hepatitis C. It was reported recently that the expression of hepatitis C virus (HCV) core protein in transgenic mice induced hepatocellular carcinoma (HCC) in association with steatosis. The objective of this study was to determine the relation between hepatic steatosis and hepatocarcinogenesis in patients with chronic HCV infection. METHODS: The authors studied 161 patients with chronic HCV infection who were diagnosed at Nagasaki University Hospital, Nagasaki, Japan, between January 1980 and December 1999. Age, gender, body mass index (BMI), habitual drinking, diabetes mellitus, serum alanine aminotransferase (ALT) level, HCV serotype, serum level of HCV core protein, interferon (IFN) treatment, hepatic fibrosis inflammation, and hepatic steatosis were studied with regard to their significance in the development of HCC using univariate and multivariate analyses. RESULTS: The cumulative incidence rates of HCC were 24%, 51%, and 63% at 5 years, 10 years, and 15 years, respectively. Multivariate analysis identified hepatic steatosis, together with aging, cirrhosis, and no IFN treatment, as independent and significant risk factors for HCC (P = 0.0135, P = 0.0390, P = 0.0068, and P = 0.0142, respectively). In addition, hepatic steatosis was correlated with BMI, serum ALT levels, and triglyceride levels. CONCLUSIONS: The findings of the current study indicate that hepatic steatosis is a risk factor for HCC in patients with chronic HCV infection. Patients with chronic HCV and hepatic steatosis should be monitored carefully for HCC. Cancer 2003;97:3036–43. © 2003 American Cancer Society. DOI 10.1002/cncr.11427
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., & Koike, K. (1998) · Nature Medicine · doi:10.1038/2053 · Cited by 1,206
Yoshida, H., Shiratori, Y., Moriyama, M., Arakawa, Y., Ide, T., Sata, M., Inoue, O., Yano, M., Tanaka, M., Fujiyama, S., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00003 · Cited by 1,096
Adinolfi, L. E., Gambardella, M., Andreana, A., Tripodi, M.-F., Utili, R., & Ruggiero, G. (2001) · Hepatology · doi:10.1053/jhep.2001.24432 · Cited by 1,059
Okuda, M., Li, K., Beard, M. R., Showalter, L. A., Scholle, F., Lemon, S. M., & Weinman, S. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.30983 · Cited by 926
Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and Steatosis
Hourigan, L. F., Macdonald, G. A., Purdie, D., Whitehall, V. H., Shorthouse, C., Clouston, A., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510290401 · Cited by 674
Metformin reverses fatty liver disease in obese, leptin-deficient mice.
Lin, H. Z., Yang, S. Q., Chuckaree, C., Kuhajda, F., Ronnet, G., & Diehl, A. M. (2000) · Nature Medicine · doi:10.1038/79697 · Cited by 673
Marrero, J. A., Fontana, R. J., Su, G. L., Conjeevaram, H. S., Emick, D. M., & Lok, A. S. (2002) · Hepatology · doi:10.1002/hep.1840360609 · Cited by 660
Barba, G., Harper, F., Harada, T., Kohara, M., Goulinet, S., Matsuura, Y., Eder, G., Schaff, Z., Chapman, M. J., Miyamura, T., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1200 · Cited by 658
Ikeda, K. (1993) · Hepatology · doi:10.1016/0270-9139(93)90505-h · Cited by 620
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3
Rubbia-Brandt, L., Quadri, R., Abid, K., Giostra, E., Malé, P.-J., Mentha, G., Spahr, L., Zarski, J.-P., Borisch, B., Hadengue, A., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80166-x · Cited by 593
Ikeda, K., Saitoh, S., Koida, I., Arase, Y., Tsubota, A., Chayama, K., Kumada, H., & Kawanishi, M. (1993) · Hepatology · doi:10.1002/hep.1840180109 · Cited by 538
Scheuer, P. J., Ashrafzadeh, P., Sherlock, S., Brown, D., & Dusheiko, G. M. (1992) · Hepatology · doi:10.1002/hep.1840150402 · Cited by 537
Moriya, K., Nakagawa, K., Santa, T., Shintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Miyazawa, T., Ishibashi, K., Horie, T., et al. (2001) · PubMed · Cited by 515
Increase in primary liver cancer in the UK, 1979–94
Taylor-Robinson, S. D., Foster, G. R., Arora, S., Hargreaves, S., & Thomas, H. C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63789-0 · Cited by 506
Bach, N., Thung, S. N., & Schaffner, F. (1992) · Hepatology · doi:10.1002/hep.1840150403 · Cited by 500
Lerat, H., Honda, M., Beard, M. R., Loesch, K., Sun, J., Yang, Y., Okuda, M., Gosert, R., Xiao, S., Weinman, S. A., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.31001 · Cited by 473
Takano, S., Yokosuka, O., Imazeki, F., Tagawa, M., & Omata, M. (1995) · Hepatology · doi:10.1002/hep.1840210308 · Cited by 432
Costet, P., Legendre, C., Moré, J., Edgar, A., Galtier, P., & Pineau, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29577 · Cited by 402
Lefkowitch, J. H., Schiff, E. R., Davis, G. L., Perrillo, R. P., Lindsay, K., Bodenheimer, H. C., Balart, L. A., Ortego, T. J., Payne, J., Dienstag, J. L., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90432-c · Cited by 368
Hepatitis C Virus Genotypes and Risk of Hepatocellular Carcinoma in Cirrhosis: A Prospective Study
Bruno, S., Silini, E., Crosignani, A., Borzio, F., Leandro, G., Bono, F., Asti, M., Rossi, S., Larghi, A., Cerino, A., et al. (1997) · Hepatology · doi:10.1002/hep.510250344 · Cited by 358
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
Nair, S., Mason, A., Eason, J., Loss, G., & Perrillo, R. P. (2002) · Hepatology · doi:10.1053/jhep.2002.33713 · Cited by 348
Changing incidence of hepatocellular carcinoma in Japan.
Okuda, K., Fujimoto, I., Hanai, A., & Urano, Y. (1987) · PubMed · Cited by 328
Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis
Czaja, A. J., & Carpenter, H. A. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)91081-r · Cited by 324
Trends in primary liver cancer
Deuffic, S., Poynard, T., Buffat, L., & Valleron, A.-J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78179-4 · Cited by 316
Hepatocellular carcinoma and hepatitis C in the United States
El-Serag, H. B. (2002) · Hepatology · doi:10.1002/hep.1840360710 · Cited by 291
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07236-5 · Cited by 230
Moradpour, D., Englert, C., Wakita, T., & Wands, J. R. (1996) · Virology · doi:10.1006/viro.1996.0397 · Cited by 227
Benvegnù, L. (1998) · Padua Research Archive (University of Padova) · Cited by 221
Significance of specific antibody assay for genotyping of hepatitis C virus
Tanaka, T. Q., Tsukiyama–Kohara, K., Yamaguchi, K., Yagi, S., Tanaka, S., Hasegawa, A., Ohta, Y., Hattori, N., & Kohara, M. (1994) · Hepatology · doi:10.1002/hep.1840190605 · Cited by 204
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A case-control study
Silini, E., Bottelli, R., Asti, M., Bruno, S., Candusso, M., Brambilla, S., Bono, F., Iamoni, G., Tinelli, C., Mondelli, M., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8698200 · Cited by 179
Yang, S. Q., Lin, H. Z., Hwang, J., Chacko, V. P., & Diehl, A. M. (2001) · PubMed · Cited by 162
Tanaka, E., Ohue, C., Aoyagi, K., Yamaguchi, K., Yagi, S., Kiyosawa, K., & Alter, H. J. (2000) · Hepatology · doi:10.1053/jhep.2000.9112 · Cited by 143
Rubbia-Brandt, L., Leandro, G., Spahr, L., Giostra, E., Quadri, R. A., Malé, P. J., & Negro, F. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01208.x · Cited by 129
Shibata, M., Morizane, T., Uchida, T., Yamagami, T., Onozuka, Y., Nakano, M., Mitamura, K., & Ueno, Y. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08002-1 · Cited by 121
Steatosis and intrahepatic hepatitis C virus in chronic hepatitis
Fujie, H., Yotsuyanagi, H., Moriya, K., Shintani, Y., Tsutsumi, T., Takayama, T., Makuuchi, M., Matsuura, Y., Miyamura, T., Kimura, S., et al. (1999) · Journal of Medical Virology · Cited by 111
Nakao, K., Nakata, K., Ohtsubo, N., Maeda, M., 森内, 拓., Ichikawa, T., Hamasaki, K., Kato, Y., Eguchi, K., Yukawa, K., et al. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05846.x · Cited by 81
Self-citationHispathology of chronic hepatitis C in relation to epidemiological factors
Delladetsima, J. K., Rassidakis, G. Z., Tassoppoulos, N. C., Papatheodoridis, G., Smyrnoff, T., & Vafiadis, I. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80182-6 · Cited by 60
Ueno, Y., Moriyama, M., Uchida, T., & Arakawa, Y. (2001) · Hepatology · doi:10.1053/jhep.2001.21902 · Cited by 58
Cited by
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
van der Meer, A. J., Veldt, B. J., Feld, J. J., Wedemeyer, H., Dufour, J.-F., Lammert, F., Duarte-Rojo, A., Heathcote, E. J., Manns, M. P., Kuske, L., et al. (2012) · JAMA · doi:10.1001/jama.2012.144878 · Cited by 1,510
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,336
Michelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974
Metadata
- Authors
- Ohata, K., Hamasaki, K., Toriyama, K., Matsumoto, K., Saeki, A., Yanagi, K., Abiru, S., Nakagawa, Y., Shigeno, M., Miyazoe, S., Ichikawa, T., Ishikawa, H., Nakao, K., & Eguchi, K.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2003-05-29
- Volume
- 97
- Issue
- 12
- Pages
- 3036-3043
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2138004489
- Cited by
- 322
- References
- 42
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.